Biogen MA Inc vs. Biozen, LLC – Trademark Opposition TTAB Proceeding 91276548

This Opposition was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on June 02, 2022 and assigned serial number 91276548 by the TTAB.

Plaintiff:
Biogen MA Inc represented by DOUGLAS A. RETTEW of FINNEGAN HENDERSON FARABOW GARRETT & DUNNER, LLP.
Trademark Information: BIOGEN – US Trademark Serial Number 86964285
View Trademark Status at USPTO
View Trademark Documents at USPTO

Defendant:
Biozen, LLC represented by DAVID M. SULLIVAN of CROWE & DUNLEVY.
Trademark Information: BIOZEN – US Trademark Serial Number 90818574
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
June 02, 2022 – FILED AND FEE
June 02, 2022 – NOTICE AND TRIAL DATES SENT; ANSWER DUE:
June 02, 2022 – INSTITUTED
July 12, 2022 – ANSWER
July 13, 2022 – TRIAL DATES REMAIN AS SET
July 29, 2022 – P MOT TO STRIKE PLEADING/AFFIRMATIVE DEFENSE
August 08, 2022 – SUSP PEND DISP OF OUTSTNDNG MOT
August 18, 2022 – D APPEARANCE / POWER OF ATTORNEY
August 18, 2022 – D OPP/RESP TO MOTION
September 01, 2022 – TRIAL DATES RESET
October 20, 2022 – D MOT FOR EXT W/ CONSENT
October 27, 2022 – EXTENSION OF TIME GRANTED
November 21, 2022 – D MOT FOR EXT W/ CONSENT
November 22, 2022 – EXTENSION OF TIME GRANTED
December 19, 2022 – P MOT FOR EXT W/ CONSENT
December 19, 2022 – EXTENSION OF TIME GRANTED
January 17, 2023 – D MOT FOR EXT W/ CONSENT
January 23, 2023 – EXTENSION OF TIME GRANTED
February 07, 2023 – P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
February 08, 2023 – SUSPENDED
March 29, 2023 – MOT TO AMEND APPLICATION
March 29, 2023 – PARTIES ALLOWED TWENTY DAYS TO RESPOND
April 11, 2023 – MOT TO AMEND APPLICATION
April 21, 2023 – RESPONSE DUE 30 DAYS (DUE DATE)
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.